Genomictree Inc. (228760.KQ)
KRW 23550.0
(3.06%)
KRW 23550.0
(3.06%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.33 Billion KRW | -539.81% |
| 2022 | 3.68 Billion KRW | 141.67% |
| 2021 | -5.79 Billion KRW | 23.2% |
| 2020 | -9.14 Billion KRW | -17.14% |
| 2019 | -9.81 Billion KRW | -264.88% |
| 2018 | -2.29 Billion KRW | -43.81% |
| 2017 | -1.96 Billion KRW | -58.88% |
| 2016 | -1.92 Billion KRW | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.6 Billion KRW | -32.57% |
| 2024 Q2 | -3.62 Billion KRW | -5.32% |
| 2023 Q1 | -3.36 Billion KRW | 35.12% |
| 2023 Q4 | -2.72 Billion KRW | 18.37% |
| 2023 FY | - KRW | -539.81% |
| 2023 Q2 | -6.76 Billion KRW | -100.91% |
| 2023 Q3 | -3.33 Billion KRW | 50.66% |
| 2022 Q2 | -2.74 Billion KRW | -119.06% |
| 2022 FY | - KRW | 141.67% |
| 2022 Q4 | -5.18 Billion KRW | -87.16% |
| 2022 Q3 | -2.77 Billion KRW | -1.14% |
| 2022 Q1 | 14.38 Billion KRW | 893.48% |
| 2021 FY | - KRW | 23.2% |
| 2021 Q3 | -3.09 Billion KRW | 0.0% |
| 2021 Q4 | -1.81 Billion KRW | 41.38% |
| 2020 FY | - KRW | -17.14% |
| 2019 FY | - KRW | -264.88% |
| 2018 FY | - KRW | -43.81% |
| 2017 FY | - KRW | -58.88% |
| 2016 FY | - KRW | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HLB Co., Ltd. | -172.27 Billion KRW | 96.325% |
| iNtRON Biotechnology, Inc. | -6.23 Billion KRW | -1.559% |
| BINEX Co., Ltd. | 10.87 Billion KRW | 158.24% |
| Bioneer Corporation | 10.04 Billion KRW | 163.046% |
| Anterogen.Co.,Ltd. | -437.82 Million KRW | -1346.204% |
| MEDIPOST Co., Ltd. | -19.39 Billion KRW | 67.348% |
| CrystalGenomics, Inc. | -42.79 Billion KRW | 85.205% |
| Helixmith Co., Ltd | -53 Billion KRW | 88.054% |
| Chabiotech Co.,Ltd. | 70.08 Billion KRW | 109.034% |
| Medy-Tox Inc. | 32.69 Billion KRW | 119.364% |
| Peptron, Inc. | -12.65 Billion KRW | 49.948% |
| Amicogen, Inc. | 13.95 Billion KRW | 145.379% |
| Genexine, Inc. | -40.87 Billion KRW | 84.51% |
| HLB Therapeutics Co.,Ltd. | 8.22 Billion KRW | 176.94% |
| LegoChem Biosciences, Inc. | -71.38 Billion KRW | 91.13% |
| ALTEOGEN Inc. | 440.04 Million KRW | 1538.917% |
| PharmaResearch Co., Ltd. | 104.25 Billion KRW | 106.073% |
| SillaJen, Inc. | -17.35 Billion KRW | 63.51% |
| JETEMA, Co., Ltd. | 11 Billion KRW | 157.522% |
| OliX Pharmaceuticals,Inc | -11.13 Billion KRW | 43.136% |
| MedPacto, Inc. | -32.6 Billion KRW | 80.582% |
| D&D Pharmatech | -9.05 Billion KRW | 30.096% |
| EASY BIO,Inc. | 24.32 Billion KRW | 126.032% |
| GI Innovation, Inc. | -51.33 Billion KRW | 87.665% |